Cytosolic calcium and lymphoproliferative response during calcium antagonism in men

European Journal of Clinical Pharmacology

Volumn 54, Issue 12, 1999, Pages 911-915

  Lijnen, P ^a,b   Fagard, R ^a   Petrov, V ^a  

^a KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Calcium; Mibefradil; Mononuclear cells

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; MAGNESIUM ION; MIBEFRADIL; PLACEBO; POTASSIUM ION; SODIUM ION;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BRADYCARDIA; CALCIUM ANTAGONISM; CALCIUM CELL LEVEL; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA SYNTHESIS; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPOTENSION; MALE; MONONUCLEAR CELL; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PARALLEL DESIGN; POTASSIUM CELL LEVEL; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; RANDOMIZED CONTROLLED TRIAL; SODIUM CELL LEVEL;

ADULT; BENZIMIDAZOLES; BLOOD PRESSURE; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELL DIVISION; DOUBLE-BLIND METHOD; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; IONS; LEUKOCYTES, MONONUCLEAR; MALE; MIBEFRADIL; PLACEBOS; POTASSIUM; PROTON PUMPS; SODIUM; TETRAHYDRONAPHTHALENES;

EID: 0033042542     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050574     Document Type: Article

References (32)

1. Rush NJ, Kotchen TA (1994) Vascular smooth muscle regulation by calcium, magnesium and potassium in hypertension. In: Swales JD (ed) Textbook of Hypertension, Blackwell, Oxford, pp 188-199
2. + exchange in the pathophysiology of essential hypertension. Am J Hypertens 9: 703-707
3. Dominiczak A, Bohr DA (1990) Cell membrane abnormalities and the regulation of intracellular calcium concentration in hypertension. Science 79: 415-423
4. Lijnen P (1995) Alterations in sodium metabolism as an etiological model for hypertension. Cardiovasc Drugs Ther 9: 377-399
5. Blaustein MP, Hamlyn JM (1984) Sodium transport inhibition, cell calcium and hypertension. Am J Med 77: 45-59
6. + antiport, protein kinase C trio in essential hypertension. Am J Hypertens 7: 205-212
7. Carr SJ, Thomas TH (1994) Perturbation of blood cell and platelet membranes in human essential hypertension. In: Swales JD (ed) Textbook of Hypertension, Blackwell, Oxford, pp 160-174
8. Erne P, Bolli P, Bürgisser E, Bühler F (1984) Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. N Engl J Med 310: 1084-1088
9. Rasmussen H, Goodman DB (1977) Relationships between calcium and cyclic nucleotides in cell activation. Physiol Rev 57: 421-509
10. Kretsinger RH (1979) The informational role of calcium in the cytosol. Adv Cyclic Nucleotide Res 11: 1-26
11. Lichtmann AH, Segel GB, Lichtmann MA (1983) The role of calcium in lymphocyte proliferation. An interpretive review. Blood 61: 413-422
12. Lijnen P, Fagard R, Petrov V (1999) Mibefradil-induced inhibition of proliferation of human peripheral blood mononuclear cells. J Cardiovasc Pharmacol (in press).
13. Lijnen P, Fagard R, Petrov V (1997) Cytosolic calcium changes induced by angiotensin II in human peripheral blood mononuclear cells are mediated via angiotensin II subtype-1 receptors. J Hypertens 15: 871-876
14. Lijnen P, Saavedra A, Petrov V (1997) In vitro proliferative response of human peripheral blood mononuclear cells to concanavalin A. Clin Chim Acta 264: 91-101
15. Battle DC, Janss G, LaPointe M, Libre J, Saleh A (1990) Cytosolic calcium in T-lymphocytes from the spontaneously hypertensive rat. Am J Hypertens 3: 343-348
16. + exchange. Clin Sci (Colch) 79: 531-536
17. + exchanger activity and NHE-1 mRNA expression in lymphocytes from patients with essential hypertension. Hypertension 25: 356-364
18. 2+ channels by Ro 40-5967. Circ Res 75: 144-148
19. Kobrin I (1997) Differential properties of mibefradil in hypertension and angina pectoris. J Hypertens 15: S33-S40
20. Morgano A, Pierri I, Stagnaro R, Setti M, Puppo F, Indiveri F (1990) Decreased lymphocyte blastogenesis, IL-2 production and NK activity following nifedipine administration to healthy humans. Eur J Clin Pharmacol 39: 545-550
21. Wittowski JM, Siebert J, Lukaszuk K, Trawicka L (1993) Comparison of effect of a panel of membrane channel blockers on the proliferative, cytotoxic and cytoadherence abilities of human peripheral blood lymphocytes. Immunopharmacology 26: 53-63
22. Jackson CL, Schwartz SM (1992) Pharmacology of smooth muscle replication. Hypertension 20: 713-736
23. Betz E (1988) The effect of calcium antagonists on intimal cell proliferation in atherogenesis. Ann N Y Acad Sci 522: 399-410
24. Agabiti-Rosei E (1995) The cardiac and vascular effects of lacidipine. J Cardiovasc Pharmacol 25: S1-S5
25. Unkelbach M, Auch-Schwelk W, Unkelbach E, Jautzke G, Fleck E (1998) Regulation of aortic wall structure by the reninangiotensin system in Wistar rats. J Cardiovasc Pharmacol 31: 31-38
26. Karam H, Heudes D, Hess R, Gonzales MF, Löffler BM, Clozel M, Clozel JP (1996) Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats. Cardiovasc Res 31: 287-295
27. Gray GA, Clozel M, Clozel JP, Baumgarter HR (1993) Effects of calcium channel blockade on the aortic intima in spontaneously hypertensive rats. Hypertension 22: 569-576
28. Schmitt R, Clozel JP, Iberg N, Bühler FR (1995) Mibefradil prevents neointima formation after vascular injury in rats. Thromb Vasc Biol 15: 1161-1165
29. Vacher E, Richer C, Fornes P, Clozel JP, Giudicelli JF (1996) Mibefradil, a selective calcium T-channel blocker, in stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 27: 686-694
30. Mulder P, Richard V, Compagnon P, Henry JP, Lallemanol F, Clozel JP, Koen R, Macé B, Thuilliez C (1997) Increased survival after long-term treatment with mibefradil, a selective T-channel calcium antagonist, in heart failure. J Am Coll Cardiol 29: 416-421
31. Nyborg NCB, Mulvany MJ (1985) Lack of effect of antihypertensive treatment with felodipine on cardiovascular structure of young spontaneously hypertensive rats. Cardiovasc Res 19: 528-536
32. Ertel SI, Ertel EA, Clozel JP (1997) T-type Ca channels and pharmacological blockade: potential pathophysiological relevance. Cardiovasc Drugs Ther 11: 723-739